October 8, 2012
Bloomberg NewsEli Lilly and Co. is betting on a “broad” range of diabetes products including pills, insulins and a once-a-week
treatment to take on bigger competitors, said Enrique Conterno, president of Lilly Diabetes.
More
October 2, 2012
Indianapolis Business Journal convened a panel of experts at its Health Care & Benefits Power Breakfast on Sept.
28 to talk about industry issues including Medicaid, on-site health clinics and narrow networks. Panelists included Robert
J. Brody, president and CEO of Franciscan St. Francis Health; Michael N. Heaton, partner, Katz Sapper & Miller; Dr. Gregory
N. Larkin, commissioner, Indiana State Department of Health; Vicki F. Perry, president, CEO, Advantage Health Solutions Inc.;
Dr. Ram Yeleti, president, Community Physician Network. The following is the unedited transcript of the discussion.
More
October 2, 2012
The unsuccessful lawsuit filed by a subsidiary of Belgium-based Bayer Bioscience claimed that insect-resistant corn products
from affiliates of Dow AgroSciences violated two of its patents.
More
September 11, 2012
J.K. WallA coalition of vegetable growers and food producers led by Indiana-based Red Gold Inc. will ease off their opposition to a
new herbicide developed by Indianapolis-based Dow AgroSciences LLC.
More
August 24, 2012
Associated PressA $100 million neuroscience center Indiana University officials say will offer a "one stop shop" for patients recovering
from head and spinal injuries, strokes and other medical conditions is days away from opening its doors in Indianapolis.
More
August 15, 2012
J.K. WallMassachusetts-based Hologic Inc., the company that bought Suros Surgical Systems Inc., will phase out its facility in Zionsville,
bringing an end to 200 local jobs.
More
July 28, 2012
J.K. WallResearch and development comes under pressure in an age of austerity.
More
July 28, 2012
Mason KingGroup sees role in cellular therapy as growth area with profit margins higher than core business.
More
July 28, 2012
Life sciences leaders discuss topics ranging from accomplishments to initial public offerings and the nature of innovation
at the July 25 event.
More
July 27, 2012
J.K. Wall
Cook Medical Inc. had been planning to open five new manufacturing plants over the next five years in small communities
around the Midwest, including Indiana, but has shelved those plans because of the hit it will take from a new U.S. tax on
medical devices.
More
July 26, 2012
The Indianapolis-based division of Dow Chemical Co. posted record second quarter sales of $1.7 billion, up 12 percent from
the year-ago period, due to a small increase in prices and the introduction of new products.
More
July 9, 2012
J.K. WallWith spending running well ahead of revenue, West Lafayette-based Bioanalytical Systems Inc. ousts its CEO in favor of its
CFO.
More
June 25, 2012
J.K. WallA new report shows Indiana’s life sciences companies performed better than their peers around the country—and
far better than the rest of Indiana’s private sector—during the early phases of the economic downturn.
More
June 18, 2012
J.K. WallThe skies got a little brighter for the orthopedic industry on Friday after Warsaw-based Biomet Inc. reported strong quarterly
sales growth of 3.4 percent. That news sparked a small surge in the stock prices of two other Warsaw-based orthopedics companies.
More
June 9, 2012
J.K. WallThe Warsaw area is well-known as the home of gigantic orthopedic implant companies and their suppliers. But now a handful
of startups have been able to raise nearly $25 million in equity investments despite the recession—putting a bit more
fuel into a fairly stagnant entrepreneurial sector.
More
June 8, 2012
Republicans in the U.S. House joined with 37 Democrats to pass a bill repealing a medical-device tax, chipping away at the
2010 health-care law in a victory for companies including Indiana-based Zimmer Holdings Inc. and Boston Scientific Corp.
More
June 4, 2012
J.K. Wall
It took the identification of 19 different genes for researchers at the Indiana University School of Medicine to develop
a test for a rare form of cancer. But their gene-hunting has paid off, as a Texas-based company announced Monday the test
is available for doctors to use.
More
May 17, 2012
Bloomberg NewsEli Lilly and other big pharmaceutical companies are creating thousands of research jobs overseas as countries led by Singapore,
Ireland and South Africa boost incentives.
More
May 14, 2012
J.K. WallIndiana has taken “a giant step backward” in the availability of early-stage capital for life sciences companies,
according to the Indiana Health Industry Forum—which also has a few ideas on how to reverse those developments.
More
May 13, 2012
Bloomberg NewsTreatments for central nervous system diseases have a huge potential payoff, analysts say. A hint of whether the gamble may
pay off is due in the second half of this year, as Eli Lilly and Co. and Pfizer Inc. announce results for Alzheimer’s drugs
that attack the same protein as Roche’s experimental drug.
More
May 12, 2012
Entrepreneurship needs broader encouragement, and is targeted in a new plan.
More
April 30, 2012
J.K. WallBioCrossroads Inc. has raised an $8.25 million seed fund in its second attempt to help startup life sciences companies grow
to the point where they can attract venture capital or a corporate funder.
More
April 26, 2012
Associated PressIndiana-based orthopedic implant maker Zimmer Holdings Inc. on Thursday reported a fractional increase in first-quarter profit
on higher sales in all global regions, particularly the Asia Pacific.
More
April 26, 2012
J.K. WallSales at Indianapolis-based Dow AgroSciences grew 14 percent in the first quarter, to $1.8 billion, helped by an early planting
season in North America and a buoyant agricultural market.
More
April 19, 2012
Associated PressThe $38 million Lyles-Porter Hall will house numerous health programs. Purdue also is planning a $25 million Drug Discovery
Building that will bring together pharmaceutical researchers from throughout the school.
More
This is a big help. Thanks for share it here.
Doug Henning!
These guy were thugs — they grew up in freaking Haughville! Smh, sigh. If the mayor needs/wants "quality" Black Hoosiers who are NOT corrupt, give me a call — I know plenty. Land bank info here - http://www.kubepharm.com/indylandbank/IndyLandBank.html
Magician and illusionist!
The basic idea of nice apartments with parking and retail is a good one, but this design seems overwhelmingly big/tall for Broad Ripple. The size could be disguised a bit with lots of big trees/landscaping, but the complex is too massive to blend in easily. That section of canal between College and Westfield will also need to be upgraded on both sides. Nice apartments facing onto a nice promenade with shade trees/plantings could bring together the canal towpath/Monon recreation, the outdoor seating at existing restaurants, and this project into something that upgrades the whole area. A plan for the whole stretch makes more sense than facing nice new housing onto what looks like a ditch. Is there a plan? Does the public have input? Who pays? The apartment idea seems to be reasonable, but Whole Foods is not a good idea for appropriate retail. Besides the store being physically too big, there are already Fresh Market at 54xCollege and Whole Foods in Nora for fancy groceries. Good Earth and Kroger are within walking distance of the Shell site. There are at least 7 grocery stores within a safe bike ride. Whole Foods would add nothing but traffic congestion. This design is on the right track, but there needs to be more work done to ensure that it blends in with and enhances the existing community. A project that large will set a tone for that whole part of town. It could be a real asset, but only if done right.